When should people with Eczema / Atopic Dermatitis (AD) be offered systemic therapy?

New consensus framework to provide a structure for patients and caregivers to make a decision about systemic therapies Atopic dermatitis (AD), also known as atopic eczema, is a common, itchy and unpleasant condition. AD has significant well-established comorbidities (associated conditions) including food allergy, asthma and allergic rhinitis, in addition to newly-recognised comorbidities including those related […]

New treatments for eczema and atopic dermatitis may be on the way

On 14 December, the US Food and Drug Administration approved the first non-steroidal therapy for eczema in more than 15 years. The drug, an ointment called Eucrisa (crisaborole), inhibits a protein called phosphodiesterase-4 and was developed by Anacor Pharmaceuticals of Palo Alto, California (a company recently acquired by Pfizer). It targets an anti-inflammatory mechanism already […]